Welcome to Kenya Association of Pharmaceutical Industry

  Contact Us : info@kapikenya.org I Member Login

All Posts Tagged: Biopharmaceutical Industry


15th January 2021

Executive Summary

The Kenya Association of Pharmaceutical Industry (KAPI) is a membership organization, established in the late 1960s, representing biopharmaceutical manufacturers (or their local representatives) that through research invent and develop medicines and technologies (e.g., Biopharmaceuticals, Vaccine Healthcare, Medical devices, Diagnostics) that significantly improve people’s lives. KAPI represents the industry voice and promotes efficiency in the pharmaceutical industry to ensure that medical products and healthcare technologies of the highest quality can be readily available for diagnosis, prevention and treatment of diseases.

Weekly Brief:

This is a roundup of news allied to the biopharmaceutical industry with a bearing on our mission to improve access to lifesaving health products and technologies for positive health outcomes.

  • World Health Organization (WHO) team of scientists arrived in Wuhan China on Thursday 14th January 2021 in plans to probe the origins of COVID-19. This comes after delays in being granted permission for the visit by the Chinese government. (The Hindu)
  • With the global COVID-19 pandemic still soaring, there have been a rise in reports of emergence of new variants of the virus. Some are associated with severe infections or rapid spread as has been noted with the South African and UK variants. Recently Kenya and the US also reported new variants. (Kenya – Nation Media; US – Financial Times)
  • German company Baxter Germany set to start the production of BioNTech/Pfizer Vaccine by early March (Reuters)
  • African Union (AU) secured an additional 270million doses of COVID-19 vaccines from Pfizer, AstraZeneca through the Serum Institute of India, and Johnson & Johnsons. (Reuters; The Presidency)
  • AstraZeneca filed for EU vaccine approval with additional information on safety, quality and efficacy. (Medical Express)
  • GlaxoSmithKline (GSK) and Vir Biotechnology are set to test their monoclonal antibody treatment for on mild to moderate COVID-19 patients within the first quarter of 2021. (Reuters)
  • Systems thinking and the application of systems thinking tools to real world problems is critical in the fight against Neglected Tropical Diseases (NTDs). (Yale Insights)
  • Progress made in the fight against superbug Acinetobacter baumannii through coupling of phages and antibiotics. (newsGP)
  • The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Speak Up Africa launched the Africa Young Innovators for Health Awards on 11th January 2021. This award seeks to fuel innovation and help advance promising healthcare solutions in the continent. (SciDev Net; Young Innovators for Health Award)

Thank You!!!

Read More

Biopharmaceutical Companies Take Lead in COVID-19 Response in Kenya

As a membership organization driven by tenets of social responsibility and commitment to public health, in the wake of COVID-19 it is in our purview to drive a common agenda to flatten the curve of transmission, build concerted efforts to ensure uninterrupted supply of medicines, diagnostics and healthcare technologies.

George Onyango, Country Manager – GlaxoSmithKline handing over donation of surgical masks to KMPDU leadership

Additionally, our member companies have been in the forefront driving action through donations in kind and financially to curtail the economic impacts of this pandemic on the less fortunate in the society. Times of hardship are when you know your true compatriots and based on the responses we’ve seen among our members we are confident as a nation we’ll emerge victorious in the end. When we count our losses and learn from this pandemic, we hope we’ll have a robust, responsive and people-centric healthcare system.

During the peak infection period coupled with stringent containment measures our member companies were involved in different initiatives as outlined below:

  1. Johnson & Johnson – Through the Kenya COVID-19 Business Response Platform committed Kshs. 5 Million to the emergency response by the government in different interventions as was necessary through a common engagement platform.
  2. Reckitt Benckiser – Through the Kenya COVID-19 Business Response Platform donated products and services to the national response team to a tune of Kshs. 13 million i.e. Kshs. 10 million worth of soap and Kshs. 3.8 million for Media Tv for public awareness and sensitization.
  3. GlaxoSmithKline – Donated surgical masks worth Kshs. 3 million to frontline healthcare workers through the Kenya Medical Practitioners Pharmacists and Dentists Union (KMPDU) to contain infection of health workers following global shortage of PPEs.
  4. AstraZeneca – Donated 35,000 surgical masks to the government to equip healthcare workers in the different isolation facilities.
  5. Bayer East Africa – Provided free IEC materials and hand sanitizers. These included fliers and posters with relevant COVID-19 information to sensitize the public and communities within which we operate both to both the employees and members of the public. Donation of five (5) handwashing water tanks to the Kenyatta National Hospital (KNH) to encourage handwashing as a preventive measure against COVID-19. The company also supported Tenwek Hospital in Bomet County with assorted PPEs including masks and gowns as well as thermos-guns and hand sanitizers.
  6. Novartis – With COVID-19, attention on other medical conditions have been at stake. On this account, when the world was marking World Sickle Cell Disease, as part of contribution to health systems strengthening and promoting care to Sickle Cell Disease Patients, Novartis offered support to the Ministry of Health, Kenya in commemorating the day. The support went into development of guidelines for the management of sickle cell disease as reported by the Chief Administrative Secretary of Health, Dr Rashid Aman.
Bayer Team at Tenwek Hospital as they donated PPEs to the facility.

These among many other interventions that were coordinated by industry leaders played a key role in shaping the trajectory of the disease in the country.

Read More